US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PMGC Holdings

4.55

+0.22005.08%

Post-market: 4.46-0.0900-1.98%19:58 EDT

Volume:55.37K

Turnover:250.98K

Market Cap:3.22M

PE:-0.01

High:4.73

Open:4.37

Low:4.34

Close:4.33

Loading ...

Overview Company News Filings

ELEVAI Labs Inc: Nasdaq Grants ELEVAI Labs Exception to Cure Bid Price Deficiency

THOMSON REUTERS

ELEVAI Labs Inc: Required to Notify Nasdaq of Significant Events Until Jan 9, 2025

THOMSON REUTERS

BRIEF-Elevai Labs Inc. Announces Update And Extension Of Pending Offer To Exchange

ELEVAI Labs Inc. Announces Update and Extension of Pending Offer to Exchange

THOMSON REUTERS

Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange

ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Engages Leading Contract Research Organization (Cro) to Support Regulatory Planning Efforts and Pre-Ind Meeting With the Food and Drug Administration for El-22 for the Treatment of Obesity

THOMSON REUTERS

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Prepare for Major Earnings Week

MT Newswires Live

BRIEF-Elevai Biosciences highlights Past Positive Preclinical Data Showing Potential Of El-32, A Dual Myostatin & Activin-A Blocker, For The Treatment Of Obesity

ELEVAI: El-32 Preclinical Results Showed Statistically Significant Increases in Grip Strength, Motor Function & Body Composition in Aged Mouse Model

THOMSON REUTERS

ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of El-32, a Dual Myostatin & Activin-a Blocker, for the Treatment of Obesity

THOMSON REUTERS

ELEVAI: to Conduct Additional Animal Studies to Advance El-32 Towards Ind Application

THOMSON REUTERS

Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity

Elevai Labs files two patent applications for EL-22 in muscle loss

Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock

Top Midday Gainers

MT Newswires Live

Crude Oil Jumps Over 4%; US Services PMI Revised Lower

Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000

Elevai Labs Unit Seeks Patents for Lead Drug Candidate to Treat Muscle Loss in Obese Patients

MT Newswires Live

ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Expands Patent Portfolio With Two New Filings for El-22 in Muscle Loss Treatment for Obese Patients, Including Glp-1 Receptor Agonist Combinations

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELAB/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":4.55,"timestamp":1743624000000,"preClose":4.33,"halted":0,"volume":55366,"hourTrading":{"tag":"盘后","latestPrice":4.46,"preClose":4.55,"latestTime":"19:58 EDT","volume":349,"amount":1570.79,"timestamp":1743638295823},"delay":0,"floatShares":543600,"shares":707106,"eps":-433.80963,"marketStatus":"Not Yet Opened","change":0.22,"latestTime":"04-02 16:00:00 EDT","open":4.3668,"high":4.73,"low":4.3376,"amount":250980.57243179998,"amplitude":0.090624,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-433.80963,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":4.33,"preHourTrading":{"tag":"盘前","latestPrice":4.44,"preClose":4.34,"latestTime":"09:29 EDT","volume":507,"amount":2206.1510289000003,"timestamp":1743600598878},"postHourTrading":{"tag":"盘后","latestPrice":4.46,"preClose":4.55,"latestTime":"19:58 EDT","volume":349,"amount":1570.79,"timestamp":1743638295823},"volumeRatio":1.164144},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","floatShares":543600,"roa":"-30.40%","roe":"-76.61%","lyrEps":-560.406084,"volumeRatio":1.164144,"shares":707106,"dividePrice":0,"high":4.73,"amplitude":0.090624,"preClose":4.33,"low":4.3376,"week52Low":3.88,"pbRate":"0.48","psRate":"1.32","week52High":1064,"institutionHeld":0,"latestPrice":4.55,"eps":-433.80963,"divideRate":0,"volume":55366,"delay":0,"ttmEps":-433.80963,"open":4.3668,"prevYearClose":16.03,"prevWeekClose":4.85,"prevMonthClose":4.63,"prevQuarterClose":4.63,"fiveDayClose":5.1,"twentyDayClose":8.61,"sixtyDayClose":17.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELAB\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2483772460","title":"ELEVAI Labs Inc: Nasdaq Grants ELEVAI Labs Exception to Cure Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2483772460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483772460?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:06","pubTimestamp":1731495970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK0XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2483214077","title":"ELEVAI Labs Inc: Required to Notify Nasdaq of Significant Events Until Jan 9, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483214077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483214077?lang=en_us&edition=fundamental","pubTime":"2024-11-13 19:06","pubTimestamp":1731495970,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nFWN3MK0XI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2481569812","title":"BRIEF-Elevai Labs Inc. Announces Update And Extension Of Pending Offer To Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2481569812","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481569812?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:47","pubTimestamp":1730760436,"startTime":"0","endTime":"0","summary":"Nov 4 (Reuters) - Elevai Labs Inc   :   * ELEVAI LABS INC. ANNOUNCES UPDATE AND EXTENSION OF PENDING OFFER TO EXCHANGESource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2481698325","title":"ELEVAI Labs Inc. Announces Update and Extension of Pending Offer to Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2481698325","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481698325?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:45","pubTimestamp":1730760339,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA6FHQQM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2481695975","title":"Elevai Labs Inc. Announces Update and Extension of Pending Offer to Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2481695975","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481695975?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:45","pubTimestamp":1730760300,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Nov.  04, 2024  (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a leader in medical aesthetics, announced today that it is has amended and rest","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/04/2974528/0/en/Elevai-Labs-Inc-Announces-Update-and-Extension-of-Pending-Offer-to-Exchange.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"gpt_icon":1},{"id":"2477370893","title":"ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Engages Leading Contract Research Organization (Cro) to Support Regulatory Planning Efforts and Pre-Ind Meeting With the Food and Drug Administration for El-22 for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2477370893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477370893?lang=en_us&edition=fundamental","pubTime":"2024-10-22 21:54","pubTimestamp":1729605266,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUAB16HSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2477330931","title":"Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2477330931","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477330931?lang=en_us&edition=fundamental","pubTime":"2024-10-22 21:54","pubTimestamp":1729605240,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Oct.  22, 2024  (GLOBE NEWSWIRE) -- EL-22 is a novel myostatin asset for the potential treatment of obesity in combination with existing GLP-1 medicinesThe Investigational New D","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/22/2967072/0/en/Elevai-Biosciences-a-Subsidiary-of-Elevai-Labs-Inc-Engages-Leading-Contract-Research-Organization-CRO-to-Support-Regulatory-Planning-Efforts-and-Pre-IND-Meeting-with-the-Food-and-D.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0690374961.EUR","BK4558","BK4183","EL","BK4504","LU2552382132.HKD","BK4548","LU0690374615.EUR","BK4588","LU2404859667.USD","BK4533","LU2404859741.USD","BK4585","LU2552382058.USD","LU2552382215.SGD","ELAB"],"gpt_icon":1},{"id":"2477985779","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Investors Prepare for Major Earnings Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2477985779","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477985779?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:58","pubTimestamp":1729515520,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 0.4% lower in Monday's premarket activity, as investors prepare for","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":[".DJI","IYE","XLF","XLP","VHT","ISBC","XSD",".IXIC","SYTA","XLE","SLV","TMUS","IVV","IYH","IYW","SASR","VIS","XRT","XLV","DAL","EXI",".SPX","IGV","FAZ","EEM","IGM","PLL","SPY","VDC","BKV","XLK","SOXX","IYK","IYJ","BITO","XLY","USO","IPK","EQR","AUB","ELAB","PMR","UNG","XLI","RTH","IBB","FAS"],"gpt_icon":1},{"id":"2477545348","title":"BRIEF-Elevai Biosciences highlights Past Positive Preclinical Data Showing Potential Of El-32, A Dual Myostatin & Activin-A Blocker, For The Treatment Of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2477545348","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477545348?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:16","pubTimestamp":1729512977,"startTime":"0","endTime":"0","summary":"Oct 21  - Elevai Labs Inc   :   * ELEVAI BIOSCIENCES, A SUBSIDIARY OF ELEVAI LABS INC., HIGHLIGHTS PAST POSITIVE PRECLINICAL DATA SHOWING POTENTIAL OF EL-32, A DUAL MYOSTATIN & ACTIVIN-A BLOCKER, FOR THE TREATMENT OF OBESITY   * ELEVAI: EL-32 PRECLINICAL RESULTS SHOWED STATISTICALLY SIGNIFICANT INCREASES IN GRIP STRENGTH, MOTOR FUNCTION & BODY COMPOSITION IN AGED MOUSE MODEL   * ELEVAI: TO CONDUCT ADDITIONAL ANIMAL STUDIES TO ADVANCE EL-32 TOWARDS IND APPLICATIONSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB"],"gpt_icon":1},{"id":"2477856439","title":"ELEVAI: El-32 Preclinical Results Showed Statistically Significant Increases in Grip Strength, Motor Function & Body Composition in Aged Mouse Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2477856439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477856439?lang=en_us&edition=fundamental","pubTime":"2024-10-21 19:30","pubTimestamp":1729510244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LX0KD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2477607856","title":"ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of El-32, a Dual Myostatin & Activin-a Blocker, for the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2477607856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477607856?lang=en_us&edition=fundamental","pubTime":"2024-10-21 19:30","pubTimestamp":1729510244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LX0KD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2477433856","title":"ELEVAI: to Conduct Additional Animal Studies to Advance El-32 Towards Ind Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2477433856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477433856?lang=en_us&edition=fundamental","pubTime":"2024-10-21 19:30","pubTimestamp":1729510244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LX0KD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2477859848","title":"Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2477859848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477859848?lang=en_us&edition=fundamental","pubTime":"2024-10-21 19:30","pubTimestamp":1729510200,"startTime":"0","endTime":"0","summary":"Preclinical results of EL-32 demonstrated statistically significant increases in grip strength, motor function and body composition in aged C57BL/6J mouse model.Elevai believes that EL-32 has the pote","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/21/2966100/0/en/Elevai-Biosciences-a-Subsidiary-of-Elevai-Labs-Inc-Highlights-Past-Positive-Preclinical-Data-Showing-Potential-of-EL-32-A-Dual-Myostatin-Activin-A-Blocker-For-the-Treatment-of-Obes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU2552382132.HKD","LU2552382058.USD","BK4183","BK4585","BK4588","BK4558","LU2404859667.USD","EL","LU2552382215.SGD","BK4504","ELAB","LU2404859741.USD","BK4548","LU0690374615.EUR","LU0690374961.EUR"],"gpt_icon":0},{"id":"2473921251","title":"Elevai Labs files two patent applications for EL-22 in muscle loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2473921251","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473921251?lang=en_us&edition=fundamental","pubTime":"2024-10-05 15:46","pubTimestamp":1728114382,"startTime":"0","endTime":"0","summary":"Elevai Labs filed two novel patent applications for its lead candidate, EL-22, aimed at treating muscle loss in obese patients. These patent applic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elevai-labs-files-two-patent-applications-for-el-22-in-muscle-loss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elevai-labs-files-two-patent-applications-for-el-22-in-muscle-loss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0690374961.EUR","ELAB","BK4558","LU2404859667.USD","LU2552382058.USD","BK4504","EL","BK4588","LU0690374615.EUR","LU2404859741.USD","BK4183","BK4548","BK4533","LU2552382132.HKD","BK4585","LU2552382215.SGD"],"gpt_icon":0},{"id":"2473918526","title":"Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2473918526","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473918526?lang=en_us&edition=fundamental","pubTime":"2024-10-05 05:08","pubTimestamp":1728076080,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Oct.  04, 2024  (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) (\"Elevai\" or the \"Company\"), a leader in medical aesthetics, today announced the commencement of an offer to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/04/2958524/0/en/Elevai-Labs-Inc-Commences-Offer-to-Exchange-Up-to-15-000-000-shares-of-Common-Stock-For-Shares-of-Non-Tradable-Locked-Up-Series-B-Preferred-Stock.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"gpt_icon":1},{"id":"2472564278","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2472564278","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472564278?lang=en_us&edition=fundamental","pubTime":"2024-10-04 02:25","pubTimestamp":1727979952,"startTime":"0","endTime":"0","summary":"Elevai Labs  said Thursday that its Elevai Biosciences subsidiary filed two patent applications for its lead candidate, EL-22, to treat muscle loss in obese patients.Shares surged 52% as intraday trading volume soared to over 477.4 million from a daily average of about 4.9 million.EVgo  said Thursday it has received a conditional commitment for a loan guarantee of up to $1.05 billion from the US Department of Energy to expand its fast charging network.Shares soared 59% as intraday trading volume catapulted to more than 100.2 million from a daily average of about 3.39 million.RBC Capital raised its price target on Vistra  to $141 from $105 while keeping its outperform rating.Shares of Vistra climbed 6.8%, with intraday trading volume at over 10.3 million compared with a daily average of about 6.9 million.Price: 0.13, Change: +0.04, Percent Change: +51.53","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELAB","IE0002270589.USD","VST","EVGO","LU2362541513.USD","IE00B19Z3B42.SGD","LU2362541273.HKD","LU1093756168.USD","LU2362540622.SGD","BK4214","BK4183","EVGO.AU","IE00B19Z3581.USD","LU1093756325.SGD","IE00BFMHRM44.USD","IE00B7SZLL34.SGD","BK4105"],"gpt_icon":1},{"id":"2472643470","title":"Crude Oil Jumps Over 4%; US Services PMI Revised Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=2472643470","media":"Benzinga","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472643470?lang=en_us&edition=fundamental","pubTime":"2024-10-04 00:12","pubTimestamp":1727971930,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41169307/crude-oil-jumps-over-4-us-services-pmi-revised-lower","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","SQQQ","BK4183","QLD","TQQQ","ANGO","QID","NVDA","BK4109","BK4526","BK4585","TOVX","BK4139","NQmain","BK4588","NGVT","BK4082","ELAB","BK4214",".IXIC","BK4023","PSQ"],"gpt_icon":1},{"id":"2472616348","title":"Dow Dips Over 100 Points; US Jobless Claims Increase To 225,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2472616348","media":"Benzinga","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472616348?lang=en_us&edition=fundamental","pubTime":"2024-10-03 21:45","pubTimestamp":1727963114,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41165087/dow-dips-over-100-points-us-jobless-claims-increase-to-225-000","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","BK4122","ELAB","QID","TOVX","BK4145","PSQ","TQQQ","QLD","BK4157","BK4183","MNQmain","BK4096","BK4023","PCOM","BK4214","CETX","PEGY","NVDA","SQQQ","BK4139","NQmain"],"gpt_icon":1},{"id":"2472719692","title":"Elevai Labs Unit Seeks Patents for Lead Drug Candidate to Treat Muscle Loss in Obese Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2472719692","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472719692?lang=en_us&edition=fundamental","pubTime":"2024-10-03 20:17","pubTimestamp":1727957828,"startTime":"0","endTime":"0","summary":"Elevai Labs  said Thursday that its Elevai Biosciences subsidiary filed two patent applications for its lead candidate, EL-22, to treat muscle loss in obese patients.The applications cover both standalone and combination therapies with GLP-1 receptor agonists, according to the company.A phase 1 study of EL-22 in South Korea has been completed, showing safety and tolerability in healthy volunteers, Elevai said, adding it plans to evaluate the investigational drug's efficacy in combination with GLP-1 to counteract muscle wasting associated with the medications while promoting weight loss.Shares of the drug developer rose more than 30% in recent premarket activity.Price: 0.1109, Change: +0.03, Percent Change: +30.16","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2472691339","title":"ELEVAI Biosciences, a Subsidiary of ELEVAI Labs Inc., Expands Patent Portfolio With Two New Filings for El-22 in Muscle Loss Treatment for Obese Patients, Including Glp-1 Receptor Agonist Combinations","url":"https://stock-news.laohu8.com/highlight/detail?id=2472691339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472691339?lang=en_us&edition=fundamental","pubTime":"2024-10-03 19:30","pubTimestamp":1727955005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241003:nFWN3LE2B1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":127}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"ELAB","defaultRemindTime":1741613400000,"type":"split","dateTimestamp":1741579200000,"forFactor":7,"toFactor":1,"ratio":7},{"market":"US","date":"2024-11-27","symbol":"ELAB","defaultRemindTime":1732717800000,"type":"split","dateTimestamp":1732683600000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELAB","date":"2025-04-01","current":-0.646723,"percent":0.867925,"low":-19.933298,"twenty":-3.335039,"median":-1.573631,"eighty":-0.955191,"high":-0.185003,"avg":-2.755991,"sd":3.226955,"marketCap":4039262},"quantilePoints":[{"date":"2023-11-24","current":-18.255744,"twenty":-17.959705,"median":-17.515646,"eighty":-17.071587,"marketCap":64119575},{"date":"2023-12-01","current":-13.864497,"twenty":-19.360956,"median":-18.255744,"eighty":-16.918634,"marketCap":48696218},{"date":"2023-12-08","current":-10.509387,"twenty":-18.255744,"median":-15.443372,"eighty":-11.703412,"marketCap":36912079},{"date":"2023-12-15","current":-8.308155,"twenty":-18.10279,"median":-11.940243,"eighty":-9.335099,"marketCap":31539899},{"date":"2023-12-22","current":-8.354717,"twenty":-17.34789,"median":-10.682077,"eighty":-8.450306,"marketCap":31716661},{"date":"2023-12-29","current":-8.216856,"twenty":-16.918634,"median":-10.164008,"eighty":-8.299025,"marketCap":31193307},{"date":"2024-01-05","current":-7.303872,"twenty":-15.709807,"median":-9.153506,"eighty":-8.280766,"marketCap":27727384},{"date":"2024-01-12","current":-8.125558,"twenty":-14.012516,"median":-8.832664,"eighty":-8.070779,"marketCap":30846714},{"date":"2024-01-19","current":-4.884465,"twenty":-13.479646,"median":-8.376629,"eighty":-7.906442,"marketCap":18542688},{"date":"2024-01-26","current":-3.42369,"twenty":-11.881035,"median":-8.330979,"eighty":-7.359564,"marketCap":12997211},{"date":"2024-02-02","current":-3.834533,"twenty":-11.486317,"median":-8.216856,"eighty":-4.738387,"marketCap":14556876},{"date":"2024-02-09","current":-2.921549,"twenty":-10.785691,"median":-8.079909,"eighty":-3.801666,"marketCap":11090953},{"date":"2024-02-16","current":-3.323718,"twenty":-10.440311,"median":-7.942961,"eighty":-3.414564,"marketCap":12617692},{"date":"2024-02-23","current":-3.218269,"twenty":-10.164008,"median":-7.897312,"eighty":-3.378041,"marketCap":12217378},{"date":"2024-03-01","current":-3.181749,"twenty":-9.179141,"median":-7.443102,"eighty":-3.218269,"marketCap":12078741},{"date":"2024-03-08","current":-3.378041,"twenty":-9.127872,"median":-4.975763,"eighty":-3.263918,"marketCap":12823915},{"date":"2024-03-15","current":-3.555616,"twenty":-8.855945,"median":-4.679044,"eighty":-3.323718,"marketCap":13498037},{"date":"2024-03-22","current":-3.491707,"twenty":-8.832664,"median":-3.834533,"eighty":-3.332848,"marketCap":13255422},{"date":"2024-03-28","current":-3.149795,"twenty":-8.668692,"median":-3.638241,"eighty":-3.254788,"marketCap":11957434},{"date":"2024-04-05","current":-2.739531,"twenty":-8.426843,"median":-3.539867,"eighty":-3.191975,"marketCap":11784138},{"date":"2024-04-12","current":-2.578785,"twenty":-8.359099,"median":-3.514988,"eighty":-3.15016,"marketCap":11092686},{"date":"2024-04-19","current":-2.356802,"twenty":-8.353987,"median":-3.494218,"eighty":-3.138017,"marketCap":10137824},{"date":"2024-04-26","current":-2.715358,"twenty":-8.317285,"median":-3.457927,"eighty":-2.966103,"marketCap":11680160},{"date":"2024-05-03","current":-2.840249,"twenty":-8.271636,"median":-3.430537,"eighty":-2.908834,"marketCap":12217378},{"date":"2024-05-10","current":-2.751214,"twenty":-8.225986,"median":-3.400866,"eighty":-2.810275,"marketCap":11834394},{"date":"2024-05-17","current":-2.439543,"twenty":-8.198597,"median":-3.378041,"eighty":-2.734696,"marketCap":11265982},{"date":"2024-05-24","current":-2.476318,"twenty":-8.139253,"median":-3.346086,"eighty":-2.649774,"marketCap":11435812},{"date":"2024-05-31","current":-2.456058,"twenty":-8.070779,"median":-3.333761,"eighty":-2.615446,"marketCap":11342250},{"date":"2024-06-07","current":-2.620224,"twenty":-8.03426,"median":-3.293818,"eighty":-2.590871,"marketCap":12100380},{"date":"2024-06-14","current":-2.536364,"twenty":-7.99774,"median":-3.211422,"eighty":-2.574044,"marketCap":11713111},{"date":"2024-06-21","current":-2.409546,"twenty":-7.933831,"median":-3.194759,"eighty":-2.543297,"marketCap":11127455},{"date":"2024-06-28","current":-2.408319,"twenty":-7.915572,"median":-3.18814,"eighty":-2.539819,"marketCap":11121788},{"date":"2024-07-05","current":-2.340001,"twenty":-7.897312,"median":-3.163489,"eighty":-2.517446,"marketCap":10806289},{"date":"2024-07-12","current":-2.148137,"twenty":-7.860792,"median":-3.149795,"eighty":-2.484198,"marketCap":9920249},{"date":"2024-07-15","current":-2.063455,"twenty":-7.842533,"median":-3.149795,"eighty":-2.476543,"marketCap":9529182},{"date":"2024-08-02","current":-1.8,"twenty":-7.824273,"median":-3.149795,"eighty":-2.472639,"marketCap":8312530},{"date":"2024-08-09","current":-1.490993,"twenty":-7.627068,"median":-3.134046,"eighty":-2.438304,"marketCap":6885510},{"date":"2024-08-16","current":-1.275527,"twenty":-7.359564,"median":-3.024259,"eighty":-2.416511,"marketCap":6059653},{"date":"2024-08-23","current":-0.996722,"twenty":-6.536966,"median":-2.921549,"eighty":-2.408074,"marketCap":4735130},{"date":"2024-08-30","current":-1.174958,"twenty":-5.249658,"median":-2.921549,"eighty":-2.362653,"marketCap":5581877},{"date":"2024-09-06","current":-1.375091,"twenty":-4.920984,"median":-2.840249,"eighty":-2.345852,"marketCap":6532648},{"date":"2024-09-13","current":-1.357574,"twenty":-4.774907,"median":-2.7913,"eighty":-2.312486,"marketCap":6449430},{"date":"2024-09-20","current":-1.33918,"twenty":-4.674479,"median":-2.751214,"eighty":-2.26391,"marketCap":6362050},{"date":"2024-09-27","current":-0.556488,"twenty":-4.272766,"median":-2.706294,"eighty":-1.721618,"marketCap":2643710},{"date":"2024-10-04","current":-0.825353,"twenty":-3.907572,"median":-2.663183,"eighty":-1.516044,"marketCap":3921009},{"date":"2024-10-11","current":-0.609011,"twenty":-3.809883,"median":-2.623475,"eighty":-1.448755,"marketCap":2893229},{"date":"2024-10-18","current":-0.543983,"twenty":-3.700324,"median":-2.618669,"eighty":-1.401366,"marketCap":2584301},{"date":"2024-10-25","current":-0.958273,"twenty":-3.624547,"median":-2.598328,"eighty":-1.356698,"marketCap":4552470},{"date":"2024-10-31","current":-0.965548,"twenty":-3.591497,"median":-2.58341,"eighty":-1.330061,"marketCap":4587034},{"date":"2024-11-08","current":-0.186042,"twenty":-3.543017,"median":-2.570883,"eighty":-1.290658,"marketCap":883831},{"date":"2024-11-15","current":-0.272307,"twenty":-3.520466,"median":-2.545057,"eighty":-1.259215,"marketCap":1293652},{"date":"2024-11-22","current":-1.912035,"twenty":-3.514988,"median":-2.532982,"eighty":-1.195453,"marketCap":10456757},{"date":"2024-11-29","current":-0.970216,"twenty":-3.514075,"median":-2.507089,"eighty":-1.176604,"marketCap":5306027},{"date":"2024-12-06","current":-0.979681,"twenty":-3.507684,"median":-2.495456,"eighty":-1.057426,"marketCap":5357793},{"date":"2024-12-13","current":-1.055406,"twenty":-3.495725,"median":-2.476318,"eighty":-1.052022,"marketCap":5771922},{"date":"2024-12-20","current":-1.320411,"twenty":-3.487233,"median":-2.449166,"eighty":-1.053364,"marketCap":7221213},{"date":"2024-12-27","current":-1.354124,"twenty":-3.469339,"median":-2.436446,"eighty":-1.055406,"marketCap":7405585},{"date":"2025-01-03","current":-1.393455,"twenty":-3.460209,"median":-2.417636,"eighty":-1.071656,"marketCap":7620685},{"date":"2025-01-10","current":-1.18556,"twenty":-3.45108,"median":-2.415433,"eighty":-1.087177,"marketCap":6483728},{"date":"2025-01-17","current":-1.208035,"twenty":-3.441037,"median":-2.409546,"eighty":-1.102066,"marketCap":6606642},{"date":"2025-01-24","current":-1.112516,"twenty":-3.431907,"median":-2.407092,"eighty":-1.109145,"marketCap":6084256},{"date":"2025-01-31","current":-0.955191,"twenty":-3.419127,"median":-2.368422,"eighty":-1.085209,"marketCap":5223856},{"date":"2025-02-07","current":-1.039472,"twenty":-3.407716,"median":-2.352273,"eighty":-1.05223,"marketCap":5684785},{"date":"2025-02-14","current":-0.955191,"twenty":-3.391736,"median":-2.340001,"eighty":-1.033105,"marketCap":5223856},{"date":"2025-02-21","current":-0.915859,"twenty":-3.378041,"median":-2.326586,"eighty":-0.998824,"marketCap":5008756},{"date":"2025-02-28","current":-0.668633,"twenty":-3.378041,"median":-2.304429,"eighty":-0.984457,"marketCap":3656699},{"date":"2025-03-07","current":-0.406293,"twenty":-3.378041,"median":-2.256137,"eighty":-0.973171,"marketCap":2221982},{"date":"2025-03-14","current":-0.413918,"twenty":-3.37165,"median":-2.063455,"eighty":-0.968145,"marketCap":2263682},{"date":"2025-03-21","current":-0.675785,"twenty":-3.34426,"median":-1.851285,"eighty":-0.96081,"marketCap":3695808},{"date":"2025-03-28","current":-0.778466,"twenty":-3.336318,"median":-1.604046,"eighty":-0.955191,"marketCap":4257365},{"date":"2025-04-01","current":-0.646723,"twenty":-3.335039,"median":-1.573631,"eighty":-0.955191,"marketCap":4039262}],"updateTime":1743645547040}}}